Fibber, the "delivery" isn't just a problem for IMU's OV. At CHM we've been now told that getting their CHM 1101 - a GBM CLTX CAR-T - into the affected brain area is a problem as well. But we've been told as well that the drugs themselves already work some " wonders ", with CHM already outperforming the current Gold Standard in clinical trials and hence the FDA request to get it to the stage of a rego trial asap. Pretty sure Team IMU has designed the trials in a way to minimise the delivery problem and has therefore entered into the co-op with the drug delivery company RenovoRx in 2023 to get on top of this general problem.
Important is that the OV / CAR-T themselves work, the delivery will be sorted out. Going back to CHM, according to the new CEO, there is improvement not too far off as this is a problem ALL companies have and a lot of research is going into that field.
GLTA
Why IMU is a multi multi bagger, page-24998
-
- There are more pages in this discussion • 1,304 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 97 | 7481668 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1703097 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |